Ovarian resection in anti-N-methyl-D-aspartate receptor encephalitis: A comparison of surgical approaches.
Ovarian resection in anti-N-methyl-D-aspartate receptor encephalitis: A comparison of surgical approaches.
复制标题
DOI:
10.3389/fneur.2022.1043785
复制
发表时间:
2022
影响因子:
3.4
通讯作者:
Tang-Wai, David F.
中科院分区:
文献类型:
--
作者:
Iyengar, Yajur;Hebert, Julien;Climans, Seth A.;Muccilli, Alexandra;Lee, Sydney;Boruah, Abhilasha P.;Thakur, Kiran T.;Solnik, Jonathon;Wennberg, Richard A.;Day, Gregory S.;Tang-Wai, David F.
For patients with anti-N-methyl-D-aspartate receptor encephalitis (NMDARE) and ovarian teratoma, “conservative” surgical approaches (complete or partial unilateral oophorectomy or bilateral partial oophorectomies) are associated with clinical improvement. “Aggressive” ovarian resections (complete bilateral oophorectomy or “blind” ovarian resections without pre-operative evidence of teratoma) are also reported, although the evidence supporting these approaches is unclear. To compare the one-year functional outcomes of patients with NMDARE who underwent conservative vs. aggressive ovarian resections. Patients with NMDARE undergoing ovarian resection between January 1st, 2012 and December 31st, 2021 were retrospectively identified from three North American tertiary care centers. Primary outcome was a modified Rankin Scale score of 0–2 one year after ovarian resection. Fisher exact and Wilcoxon rank sum tests were used to compare demographic features, disease characteristics, and functional outcomes between the two surgical groups. A fixed-effects meta-analysis of studies reporting functional outcomes based on surgical approach was also performed. Twenty-three patients were included. Eight underwent aggressive surgical management. There was a non-significant trend toward an association between aggressive surgical management and younger age-at-onset, higher baseline disease severity, and longer delays to treatment. There was no difference between “aggressive” (3/8, 38%) and “conservative” (11/15, 73%) management groups in achieving the primary outcome (OR95% = <0.1–1.9; p = 0.18). Findings were similar when considering data from 52 patients in two published studies (RR = 0.74; CI95% = 0.48–1.13; p = 0.16). Aggressive ovarian resection was not associated with improved outcomes in patients with NMDARE in this series. Group differences may have contributed, recognizing that patients who underwent aggressive resection tended to be sicker, with procedures performed later in the disease course. Based on available evidence, we advocate for function-sparing resection in patients with imaging-confirmed/suspected teratoma, and repeated multi-modal imaging in at-risk patients with NMDARE refractory to conventional treatment.
登录
查看更多内容
DOI:
10.3988/jcn.2021.17.1.131
发表时间:
2021-01
期刊:
Journal of clinical neurology (Seoul, Korea)
影响因子:
--
作者:
Hong SB;Shin YW;Shin YW;Lee SK;Chu K
通讯作者:
Chu K
影响因子:
9.9
作者:
Balu, Ramani;McCracken, Lindsey;Titulaer, Maarten J.
通讯作者:
Titulaer, Maarten J.
影响因子:
29
作者:
Day, Gregory S.;Laiq, Simin;Munoz, David G.
通讯作者:
Munoz, David G.
影响因子:
5.6
作者:
Wu CY;Wu JD;Chen CC
通讯作者:
Chen CC
DOI:
10.1016/j.eurox.2021.100129
发表时间:
2021-07
影响因子:
--
作者:
El Hanna J;Quenum C;Arsalane A
通讯作者:
Arsalane A